DE69733942T2 - Mcbi analoge von cc-1065 und die duocarmycine - Google Patents

Mcbi analoge von cc-1065 und die duocarmycine Download PDF

Info

Publication number
DE69733942T2
DE69733942T2 DE69733942T DE69733942T DE69733942T2 DE 69733942 T2 DE69733942 T2 DE 69733942T2 DE 69733942 T DE69733942 T DE 69733942T DE 69733942 T DE69733942 T DE 69733942T DE 69733942 T2 DE69733942 T2 DE 69733942T2
Authority
DE
Germany
Prior art keywords
mcbi
hours
alkylation
dna
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69733942T
Other languages
German (de)
English (en)
Other versions
DE69733942D1 (de
Inventor
L. Dale BOGER
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scripps Research Institute
Original Assignee
Scripps Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Institute filed Critical Scripps Research Institute
Publication of DE69733942D1 publication Critical patent/DE69733942D1/de
Application granted granted Critical
Publication of DE69733942T2 publication Critical patent/DE69733942T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/60—Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/70—[b]- or [c]-condensed containing carbocyclic rings other than six-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Auxiliary Devices For And Details Of Packaging Control (AREA)
  • Dc Digital Transmission (AREA)
  • Silicon Polymers (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Electrotherapy Devices (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
DE69733942T 1996-03-08 1997-03-07 Mcbi analoge von cc-1065 und die duocarmycine Expired - Fee Related DE69733942T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1302496P 1996-03-08 1996-03-08
US13024P 1996-03-08
PCT/US1997/003641 WO1997032850A1 (en) 1996-03-08 1997-03-07 Mcbi analogs of cc-1065 and the duocarmycins

Publications (2)

Publication Number Publication Date
DE69733942D1 DE69733942D1 (de) 2005-09-15
DE69733942T2 true DE69733942T2 (de) 2006-06-08

Family

ID=21757922

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69733942T Expired - Fee Related DE69733942T2 (de) 1996-03-08 1997-03-07 Mcbi analoge von cc-1065 und die duocarmycine

Country Status (9)

Country Link
US (1) US5985908A (cg-RX-API-DMAC10.html)
EP (1) EP0888301B1 (cg-RX-API-DMAC10.html)
JP (1) JP2000506168A (cg-RX-API-DMAC10.html)
AT (1) ATE301639T1 (cg-RX-API-DMAC10.html)
AU (1) AU711974B2 (cg-RX-API-DMAC10.html)
CA (1) CA2246783C (cg-RX-API-DMAC10.html)
DE (1) DE69733942T2 (cg-RX-API-DMAC10.html)
ES (1) ES2244991T3 (cg-RX-API-DMAC10.html)
WO (1) WO1997032850A1 (cg-RX-API-DMAC10.html)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6060608A (en) * 1996-05-31 2000-05-09 The Scripps Research Institute Analogs of CC-1065 and the duocarmycins
WO1998011101A2 (en) * 1996-09-12 1998-03-19 Cancer Research Campaign Technology Limited Condensed n-aclyindoles as antitumor agents
US6130237A (en) * 1996-09-12 2000-10-10 Cancer Research Campaign Technology Limited Condensed N-aclyindoles as antitumor agents
WO1998025900A1 (en) * 1996-12-13 1998-06-18 Shionogi & Co., Ltd. Compounds having antitumor activity
JP3649617B2 (ja) * 1999-03-26 2005-05-18 独立行政法人科学技術振興機構 ２本鎖ｄｎａを切断できる化合物及びその使用方法
JP5010089B2 (ja) * 2000-09-19 2012-08-29 スピロジェン リミテッド Ｃｃ−１０６５およびデュオカルマイシンのアキラルアナログの組成物およびその使用方法
DE60211905T2 (de) * 2001-02-22 2007-01-18 School Of Pharmacy, University Of London Benz-indol- und benzo-chinolin-derivate als prodrugs zur tumorbehandlung
EP1409480B1 (en) 2001-02-22 2007-11-14 The School Of Pharmacy, University Of London Pyrrolo-indole and pyrrolo-quinoline derivatives as prodrugs for tumour treatment
MXPA03011094A (es) 2001-05-31 2004-12-06 Medarex Inc Citotoxinas, profarmacos, ligadores, y estabilizadores utiles para ello.
AU2003287160A1 (en) * 2002-10-15 2004-05-04 Rigel Pharmaceuticals, Inc. Substituted indoles and their use as hcv inhibitors
JPWO2005087762A1 (ja) 2004-03-13 2008-01-24 テムリック株式会社 Ｄｎａの特定塩基配列をアルキル化する新規インドール誘導体ならびにそれを用いたアルキル化剤および薬剤
CA2564076C (en) 2004-05-19 2014-02-18 Medarex, Inc. Chemical linkers and conjugates thereof
RU2402548C2 (ru) 2004-05-19 2010-10-27 Медарекс, Инк. Химические линкеры и их конъюгаты
US7714016B2 (en) 2005-04-08 2010-05-11 Medarex, Inc. Cytotoxic compounds and conjugates with cleavable substrates
WO2007051081A1 (en) * 2005-10-26 2007-05-03 Medarex, Inc. Methods and compounds for preparing cc-1065 analogs
WO2007059404A2 (en) 2005-11-10 2007-05-24 Medarex, Inc. Duocarmycin derivatives as novel cytotoxic compounds and conjugates
TWI412367B (zh) 2006-12-28 2013-10-21 Medarex Llc 化學鏈接劑與可裂解基質以及其之綴合物
WO2008103693A2 (en) 2007-02-21 2008-08-28 Medarex, Inc. Chemical linkers with single amino acids and conjugates thereof
US9901567B2 (en) 2007-08-01 2018-02-27 Syntarga B.V. Substituted CC-1065 analogs and their conjugates
AU2009320481C1 (en) 2008-11-03 2016-12-08 Syntarga B.V. Novel CC-1065 analogs and their conjugates
WO2011133039A2 (en) 2010-04-21 2011-10-27 Syntarga B.V. Novel conjugates of cc-1065 analogs and bifunctional linkers
EP2762472B1 (en) * 2011-09-28 2017-05-24 Industry-Academia Cooperation Group of Sejong University Selenophene-fused aromatic compound and manufacturing method thereof
ES2701076T3 (es) 2012-11-24 2019-02-20 Hangzhou Dac Biotech Co Ltd Enlazadores hidrofílicos y sus usos para la conjugación de fármacos a las moléculas que se unen a las células
CN105102455B (zh) 2012-12-21 2018-05-25 荷商台医(有限合伙)公司 亲水性自消耗连接子及其缀合物
MY177390A (en) 2014-01-10 2020-09-14 Byondis Bv Method for purifying cys-linked antibody-drug conjugates
FI3122757T3 (fi) 2014-02-28 2023-10-10 Hangzhou Dac Biotech Co Ltd Varautuneita linkkereitä ja niiden konjugointikäyttötapoja
SG11201610620UA (en) 2014-06-20 2017-01-27 Bioalliance Cv Anti-folate receptor aplha (fra) antibody-drug conjugates and methods of using thereof
EP4678240A2 (en) 2015-07-12 2026-01-14 Hangzhou Dac Biotech Co., Ltd. Bridge linkers for conjugation of cell-binding molecules
US9839687B2 (en) 2015-07-15 2017-12-12 Suzhou M-Conj Biotech Co., Ltd. Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
ES2880731T3 (es) 2016-01-08 2021-11-25 Altrubio Inc Anticuerpos anti-PSGL-1 tetravalentes y usos de los mismos
MX2019005583A (es) 2016-11-14 2019-10-21 Hangzhou Dac Biotech Co Ltd Vinculantes de conjugacion, conjugados de molecula de union a celulas que contienen los vinculantes, metodos de creacion y usos de dichos conjugados con los vinculantes.
KR102894542B1 (ko) 2020-01-30 2025-12-03 (주)에임드바이오 벤조셀레노펜계 화합물, 이를 포함하는 약학적 조성물 및 항체-약물 결합체
KR20240095442A (ko) 2021-11-03 2024-06-25 항저우 디에이씨 바이오테크 씨오, 엘티디 항체의 특이적 접합

Also Published As

Publication number Publication date
AU1990297A (en) 1997-09-22
EP0888301A1 (en) 1999-01-07
DE69733942D1 (de) 2005-09-15
WO1997032850A1 (en) 1997-09-12
US5985908A (en) 1999-11-16
EP0888301B1 (en) 2005-08-10
CA2246783A1 (en) 1997-09-12
AU711974B2 (en) 1999-10-28
ES2244991T3 (es) 2005-12-16
JP2000506168A (ja) 2000-05-23
ATE301639T1 (de) 2005-08-15
EP0888301A4 (en) 2002-05-08
CA2246783C (en) 2006-07-11

Similar Documents

Publication Publication Date Title
DE69733942T2 (de) Mcbi analoge von cc-1065 und die duocarmycine
DE69208496T2 (de) Bernsteinsäurederivate
EP0090362A2 (de) Neue Derivate von Cycloalka(c)pyrrol-carbonsäuren, Verfahren zu ihrer Herstellung, diese enthaltende Mittel und deren Verwendung sowie neue Cycloalka(c)pyrrol-carbonsäuren als Zwischenstufen und Verfahren zu deren Herstellung
DE69710181T2 (de) 7-amino-2-heptenoate und ihre verwendung in der herstellung von methylphenidat
EP0031080A1 (de) 2-Acylaminomethyl-1,4-benzodiazepine und deren Salze sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE69119933T2 (de) Hexahydro[cd]indole
DE69217783T2 (de) 3-Phenoxybenzyl(iden)pyrrolidin-Derivate, deren Herstellung und deren Verwendung als muskarin-cholinerge Mittel
DD264920A5 (de) Verfahren zur herstellung von (+)-biotin
DE3686232T2 (de) Lactamderivate, deren herstellung und deren benutzung als hypotensive mittel.
DE10115408A1 (de) Benzofuran-Derivate
DD147110A5 (de) Verfahren zur herstellung von 9-eckige klammer auf 3-(3.5-cis-dimethylpiperazino)-propyl eckige klammer zu-carbazol und dessen salzen
DE3823919A1 (de) 3-substituierte benzazepine
DE2619458A1 (de) 7 beta -acylamino-6 alpha h-8-oxo-4thia-1-azabicyclo eckige klammer auf 4.2.0 eckige klammer zu oct-2-en-2- carbonsaeure-derivate, verfahren zu ihrer herstellung, arzneimittel und zwischenprodukte
DE68925173T2 (de) 4-Methyl und 4-Ethyl substituierte Pyrrolidin-2-one
EP0389425B1 (de) Neue Benzothiopyranylamine
DE1695416A1 (de) Benzomorphan-derivate und Verfahren zu deren Herstellung
DE1695435A1 (de) Indolyl-aliphatische Saeuren
DE68905363T2 (de) Heterotetracyclische laktamderivate, verfahren zu ihrer herstellung und pharmazeutische zubereitungen, die sie enthalten.
EP0266308B1 (de) Indolo-pyrazino-benzodiazepin-Derivate
DE60002303T2 (de) Verfahren zur herstellung von paroxetin
DE69630184T2 (de) Verfahren zur Herstellung von 1-substituierten Pyrrol-3-carbonsäure-Derivaten
DE1695941A1 (de) Verfahren zur Herstellung von 5-gliedrigen N-Heterocyclen,die im Ring ungesaettigt sind
EP0187619A2 (de) 1,3-disubstituierte Tetrahydropyridine
DE69715402T2 (de) Verfahren zur herstellung von pyrrolidin-derivaten
DE69121920T2 (de) Antagonisten reizübertragender aminosäuren

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee